Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)
© The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike immunoglobulin G (IgG) titers compared with those with severe coronavirus disease 2019, likely reflecting a longer time since the onset of infection in MIS-C patients.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Journal of the Pediatric Infectious Diseases Society - 10(2021), 5 vom: 28. Mai, Seite 669-673 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Anderson, Elizabeth M [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 03.06.2021 Date Revised 01.04.2022 published: Print UpdateOf: medRxiv. 2020 Aug 18;:. - PMID 32839782 Citation Status MEDLINE |
|---|
| doi: |
10.1093/jpids/piaa161 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318299801 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318299801 | ||
| 003 | DE-627 | ||
| 005 | 20231225165049.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jpids/piaa161 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM318299801 | ||
| 035 | |a (NLM)33263756 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Anderson, Elizabeth M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19) |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.06.2021 | ||
| 500 | |a Date Revised 01.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a UpdateOf: medRxiv. 2020 Aug 18;:. - PMID 32839782 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike immunoglobulin G (IgG) titers compared with those with severe coronavirus disease 2019, likely reflecting a longer time since the onset of infection in MIS-C patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-COV-2 | |
| 650 | 4 | |a antibodies | |
| 650 | 4 | |a multisystem inflammatory syndrome in children (MIS-C) | |
| 650 | 4 | |a pediatric | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Immunoglobulin A |2 NLM | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Immunoglobulin M |2 NLM | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 700 | 1 | |a Diorio, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Goodwin, Eileen C |e verfasserin |4 aut | |
| 700 | 1 | |a McNerney, Kevin O |e verfasserin |4 aut | |
| 700 | 1 | |a Weirick, Madison E |e verfasserin |4 aut | |
| 700 | 1 | |a Gouma, Sigrid |e verfasserin |4 aut | |
| 700 | 1 | |a Bolton, Marcus J |e verfasserin |4 aut | |
| 700 | 1 | |a Arevalo, Claudia P |e verfasserin |4 aut | |
| 700 | 1 | |a Chase, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Hicks, Philip |e verfasserin |4 aut | |
| 700 | 1 | |a Manzoni, Tomaz B |e verfasserin |4 aut | |
| 700 | 1 | |a Baxter, Amy E |e verfasserin |4 aut | |
| 700 | 1 | |a Andrea, Kurt P |e verfasserin |4 aut | |
| 700 | 1 | |a Burudpakdee, Chakkapong |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Jessica H |e verfasserin |4 aut | |
| 700 | 1 | |a Vella, Laura A |e verfasserin |4 aut | |
| 700 | 1 | |a Henrickson, Sarah E |e verfasserin |4 aut | |
| 700 | 1 | |a Harris, Rebecca M |e verfasserin |4 aut | |
| 700 | 1 | |a Wherry, E John |e verfasserin |4 aut | |
| 700 | 1 | |a Bates, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Bassiri, Hamid |e verfasserin |4 aut | |
| 700 | 1 | |a Behrens, Edward M |e verfasserin |4 aut | |
| 700 | 1 | |a Teachey, David T |e verfasserin |4 aut | |
| 700 | 1 | |a Hensley, Scott E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the Pediatric Infectious Diseases Society |d 2012 |g 10(2021), 5 vom: 28. Mai, Seite 669-673 |w (DE-627)NLM227436326 |x 2048-7207 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2021 |g number:5 |g day:28 |g month:05 |g pages:669-673 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jpids/piaa161 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2021 |e 5 |b 28 |c 05 |h 669-673 | ||